Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Acanthosis Nigricansin PCOS Patients and Its Relation with Type 2 Diabetes Mellitus and Body Mass at a Tertiary Care Hospital in Southern India.

G S, A B, Kamath A, Shivaprakash P, Adhikari P, Up R, Hn G, Padubidri JR.

J Clin Diagn Res. 2013 Feb;7(2):317-9. doi: 10.7860/JCDR/2013/4930.2756. Epub 2013 Feb 1.

2.

Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.

Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.

Neuro Endocrinol Lett. 2007 Dec;28(6):807-10.

PMID:
18063948
3.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society.

Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Review.

PMID:
26642102
4.

[Obese children with benign acanthosis nigricans and insulin resistance: analysis of 19 cases].

Fu JF, Liang L, Dong GP, Jiang YJ, Zou CC.

Zhonghua Er Ke Za Zhi. 2004 Dec;42(12):917-9. Chinese.

PMID:
15733362
5.

Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome.

Charnvises K, Weerakiet S, Tingthanatikul Y, Wansumrith S, Chanprasertyothin S, Rojanasakul A.

Gynecol Endocrinol. 2005 Sep;21(3):161-4.

PMID:
16335908
6.

Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.

Ehrmann DA, Kasza K, Azziz R, Legro RS, Ghazzi MN; PCOS/Troglitazone Study Group.

J Clin Endocrinol Metab. 2005 Jan;90(1):66-71. Epub 2004 Oct 26.

PMID:
15507516
7.

Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index.

Saxena P, Prakash A, Nigam A, Mishra A.

Indian J Endocrinol Metab. 2012 Nov;16(6):996-9. doi: 10.4103/2230-8210.103011.

8.

Insulin resistance and lipid accumulation product in corelation to body mass index in women with polycystic ovary syndrome.

Godinjak A, Godinjak Z, Burekovic A, Surkovic I, Dizdarevic-Bostandzic A, Velija-Asimi Z.

Med Arch. 2012;66(6):409-11.

PMID:
23409523
9.

Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.

Yildiz BO, Yarali H, Oguz H, Bayraktar M.

J Clin Endocrinol Metab. 2003 May;88(5):2031-6.

PMID:
12727950
10.

Frequency of prediabetes in women with polycystic ovary syndrome.

Ibricevic D, Asimi ZV.

Med Arch. 2013;67(4):282-5.

PMID:
24520755
11.

Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran.

Mirzaei F, Kazemi N.

Metab Syndr Relat Disord. 2008 Sep;6(3):215-7. doi: 10.1089/met.2008.0015.

PMID:
18710333
12.

Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.

Taskin MI, Bulbul E, Adali E, Hismiogulları AA, Inceboz U.

Eur J Obstet Gynecol Reprod Biol. 2015 Jun;189:19-23. doi: 10.1016/j.ejogrb.2015.03.006. Epub 2015 Mar 9.

PMID:
25837320
13.

Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.

Wijeyaratne CN, Seneviratne Rde A, Dahanayake S, Kumarapeli V, Palipane E, Kuruppu N, Yapa C, Seneviratne Rde A, Balen AH.

Hum Reprod. 2011 Jan;26(1):202-13. doi: 10.1093/humrep/deq310. Epub 2010 Nov 23.

PMID:
21098627
14.

Assessment of impaired glucose tolerance prevalence with hemoglobin A₁c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study.

Celik C, Abali R, Bastu E, Tasdemir N, Tasdemir UG, Gul A.

Hum Reprod. 2013 Apr;28(4):1062-8. doi: 10.1093/humrep/det002. Epub 2013 Jan 18.

PMID:
23335611
15.

Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent.

Ganie MA, Dhingra A, Nisar S, Sreenivas V, Shah ZA, Rashid A, Masoodi S, Gupta N.

Fertil Steril. 2016 Jan;105(1):194-201.e1-3. doi: 10.1016/j.fertnstert.2015.09.005. Epub 2015 Sep 25.

PMID:
26407537
16.

Association of acanthosis nigricans with insulin resistance in patients with polycystic ovary syndrome.

Panidis D, Skiadopoulos S, Rousso D, Ioannides D, Panidou E.

Br J Dermatol. 1995 Jun;132(6):936-41.

PMID:
7662572
17.
18.

Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.

Kelestimur F, Unluhizarci K, Baybuga H, Atmaca H, Bayram F, Sahin Y.

Fertil Steril. 2006 Aug;86(2):405-10. Epub 2006 Jun 8.

PMID:
16762349
19.

High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).

Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.

Gynecol Endocrinol. 2014 Nov;30(11):781-4. doi: 10.3109/09513590.2014.924099. Epub 2014 Aug 19.

PMID:
25137507
20.

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.

Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, Casimirri F, Morselli-Labate AM.

Clin Endocrinol (Oxf). 1999 Apr;50(4):517-27.

PMID:
10468913

Supplemental Content

Support Center